/
We are a leading global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. We entered the life sciences market in 2011, leveraging our in-house precision automation and cryogenics capabilities that we were then applying in the semiconductor manufacturing market.
The business is unprofitable at the operating level (-4.52% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$599M
Net Income (TTM)
-$173M
Op. Margin
-28.88%
ROIC
-8.49%
Cash Flow & Balance Sheet
FCF (TTM)
$30M
Op. Cash Flow (TTM)
$62M
Net Debt
-$325M
Net Cash Position
Cash & Equiv.
$381M
5Y CAGR: +8.9%
Continue Research